Ribonucleic Acid (RNA) Sequencing Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

How Big Is the Ribonucleic Acid (RNA) Sequencing Market Expected to Be, and What Will Its Growth Rate Be?
The drastic expansion of the ribonucleic acid (RNA) sequencing market has been noticeable in recent times, escalating from a value of $3.25 billion in 2024 to a projected $3.98 billion in 2025, at a compound annual growth rate (CAGR) of 22.7%. Various determinants can explain the growth recorded in the past, these include the climb in drug development initiatives, the surge in genetic disorders and targeted diseases, the escalating use of compact, portable tools, increasing importance given to biomarker profiling, higher demand for tailored medical treatments, and a rise in the number of cancer patients.

In the coming years, the RNA (ribonucleic acid) sequencing market is anticipated to undergo accelerated growth. By the year 2029, experts estimate the market will have grown to $8.91 billion, with a CAGR of 22.3%. Factors contributing to the predicted growth include an increase in the need for fast and accurate disease diagnoses, rising acceptance of real-time polymerase chain reaction, on-site diagnostic testing demand, escalation in infectious disease outbreaks, and the need for companion diagnostics. Key trends for the predicted duration are disease tracking and detection, drug research, target verification, biomarker recognition, DNA sequencing technologies, advancements in diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of sophisticated molecular diagnostic solutions.

What Is Stimulating Growth in the Ribonucleic Acid (RNA) Sequencing Market?
The burgeoning emphasis on precision medicine is anticipated to drive the expansion of the ribonucleic acid (RNA) sequencing market in the future. Various individual factors, such as genes, environment, and lifestyle, are considered in precision medicine, promising a new frontier in medical treatment and prevention. It offers more efficient treatments, breakthroughs in genomics, rising disease complexity, and regulatory support. RNA sequencing methodologies are employed to assess the sequence and quantify the expression levels of RNA molecules in a particular sample, providing a comprehensive examination of transcriptomes and insights into gene expression patterns, alternative splicing events, and RNA modifications. For instance, the Personalized Medicine Coalition, a non-profit entity based in the US, reported in February 2024 that the FDA had approved 16 new personalized therapies for patients suffering from rare diseases in 2023, a significant increase from the six approved in 2022. As a result, the growing emphasis on precision medicine is fueling the growth of the ribonucleic acid (RNA) sequencing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Who Are the Dominant Companies Influencing Ribonucleic Acid (RNA) Sequencing Market Trends?
Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

How Is the Ribonucleic Acid (RNA) Sequencing Market Evolving?
The focus of key players in the ribonucleic acid (RNA) sequencing market is on enhancing patient treatment by applying RNA next-generation sequencing assay and capitalizing on precision medicine and insights gathered from data. This next-generation exome sequencing platform, RNA next-generation sequencing assay, uses cutting-edge genomic sequencing technologies to delineate a patient's total exome. To illustrate, Tempus, a precision medicine technology firm based in the US, rolled out Tempus xR, its novel standalone RNA next-generation sequencing assay, in June 2023. Primarily designed for solid tumors, this groundbreaking assay provides an all-encompassing analysis of the full transcriptome. It emphasizes clinically important fusions in over 100 targeted genes and deviation in splicing for MET Exon 14 and EGFRvIII. The assay serves physicians interested in RNA fusions or altered splicing, and providers, researchers, and biopharmaceutical companies needing comprehensive RNA sequencing analysis of their available samples.

What Are the Different Segmentations in the Ribonucleic Acid (RNA) Sequencing Market?
The ribonucleic acid (RNA) sequencing market covered in this report is segmented -

1) By Product Type: Instruments, Reagents And Kits, Software
2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications
4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments
2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits
3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Region Is at the Forefront of the Ribonucleic Acid (RNA) Sequencing Market?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Ribonucleic Acid (RNA) Sequencing Global Market Report?

- Market Size Analysis: Analyze the Ribonucleic Acid (RNA) Sequencing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Ribonucleic Acid (RNA) Sequencing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Ribonucleic Acid (RNA) Sequencing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Ribonucleic Acid (RNA) Sequencing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.